2008-11-11 09:22:40 EST
Phoenix, AZ - (WORLD STOCK WIRE) - November 11, 2008 -- JZZ Technologies, Inc. (OTC Pink Sheets: JZZI) announced today that Dr. Steven Levin of the Advanced Diagnostic Pain Treatment Centers at Yale New Haven Medical has assumed the role of acting Chief Medical Officer (CMO) and has joined the Board of Directors.
.
Dr. Levin graduated with a degree in molecular genetics from the University of Pennsylvania in 1986. He received his medical degree from the University Of Pittsburgh School Of Medicine in 1990. He then completed his residency in anesthesiology and fellowship in Pain Management before joining the faculty of the University of Pittsburgh in 1995.
.
During his tenure on the University of Pittsburgh faculty, Dr. Levin was an attending physician at the internationally renowned pain management rehabilitation center, he co-developed the interventional pain management program, and he developed and directed a cancer pain service.
.
In 1997 Dr. Levin was recruited to the Yale University School of Medicine. In 1998 he assumed the directorship of the Yale Pain Management Fellowship. Since arriving in Connecticut, Dr. Levin has remained committed to making quality pain management services available to patients. He has served as a Chairman of the American Cancer Society's Connecticut Cancer Pain Initiative, a pain management consultant to the Connecticut Hospice, and has been an active advocate in support of state legislation giving patients access to pain management services.
.
Dr. Levin has published numerous articles and has lectured throughout the country on the management of chronic, cancer, and acute pain. He has also conducted research in the area of pain management and novel analgesic agents. He currently serves as a co-editor of “The Pain Clinic”, the official journal of the World Society of Pain Clinicians. Dr. Levin has applied his remarkable breadth of pain management experience as a physician and board member at the Advance Diagnostic Pain Management Treatment Center, which was formed to replace the Yale Center for Pain Management.
.
Dr Levin had this to say about JZZ Technologies latest advancement in range of motion assessment systems, ROMTech. “Until the recent advent of JZZ’s applied computer technology software entitled ROMTech, range of motion determinations, which are critical to many impairment ratings, have largely been a matter of clinical estimation. Even by employing the most sensitive clinical measures currently utilized, range of motion determinations are subject to large variations and potential errors. The use of ROMTech’s precise computer aided range of motion determination methodologies allows for patient effort to be statistically analyzed thereby providing validity data and insuring testing integrity.”
.
Safe Harbor Statement:
Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performances or achievements express or implied by such forward-looking statements. The forward-looking statements are subject to risks and uncertainties including, without limitation, changes in levels of competition, possible loss of customers, and the company's ability to attract and retain key personnel.
.
Investor & Media Relations
WSMG
Tel: 760-329-4169
email: jzzi@wsmg.biz
.
Aaron Pines, President
JZZ Technologies, Inc.
10429 S. 51st Street
Suite 245
Phoenix, AZ 85044
USA
Phone: 866-871-8324
Fax: 877-745-3369
.
Source: JZZ Technologies, Inc.
Note: The following press release was submitted by: JZZ Technologies, Inc., and World Stock Wire, Inc. is not liable for the contents of this press release.
No comments:
Post a Comment